Tempus AI is trading $65.18, 4.77% up after its September 15, 2026 appearance at the Morgan Stanley 24th Annual Global Healthcare Conference, where management highlighted durable diagnostics growth and expanding data licensing.
- The broader software-sector rotation also supports sentiment.
- Tempus AI closed September 14, 2026 at $62.21, up 5.42%, indicating continued momentum into the conference session.
- No new earnings release or regulatory announcement was identified.